This message was sent to ##Email##
|
|
|
|
SCAI
SCAI TV captures the latest news coming from the Scientific Sessions. Save the playlist to your watchlist today!
Access SCAI TV
Ajay Kirtane, MD, SM, FSCAI, chats with C. Michael Gibson, MD, FSCAI, on what interventional cardiologists need in their complex PCI toolbox at the SCAI 2018 Scientific Sessions in San Diego, Calif.
|
SCAI-TV video production at SCAI 2018 Scientific Sessions is supported in part by Medtronic. We gratefully acknowledge this support while taking sole responsibility for all content developed and disseminated through the program.
|
Pulsara
In the cohort of patients, the utilization of the Pulsara platform decreased the average door-to-balloon times by 22% in patients with acute STEMI arriving at the emergency department. This effect was maintained when looking at the subset of all STEMI cases reportable to CMS. Researchers also observed modest improvements in meeting the less than 60-minute, less than 90-minute benchmarks, and improvements in the resource utilization. Read the full Critical Pathways in Cardiology publication here.
READ MORE
|
|
|
|
|
Doximity Op-(m)ed
Dr. Srihari S. Naidu, MD, writes: "As I write this, I am recovering from a red eye flight after four days in San Diego at the 2018 Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions. By all indications the meeting was an astounding success, with the highest attendance of physicians, industry colleagues and fellows-in-training, and a jam-packed yet clearly organized flow of educational sessions for everyone.
From my standpoint, one of my major clinical interests is the diagnosis and management of cardiogenic shock."
READ MORE
SCAI via News-Medical.Net
Results of the AVIATOR 2 international registry are being presented as late-breaking clinical science at the Society for Cardiovascular Angiography and Interventions 2018 Scientific Sessions. The AVIATOR 2 is a multicenter prospective observational study of patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention in 11 international sites. The use of a novel smartphone-based survey was used to capture physician and patient perspectives regarding antithrombotic therapies after PCI.
READ MORE
SCAI via Healio
The Society for Cardiovascular Angiography and Interventions announced at its annual meeting the launch of the SCAI PAD Diagnosis and Treatment Resource Center, an ongoing, patient-centered quality improvement initiative focused on raising awareness of peripheral artery disease in the cardiology and internal medicine communities.
READ MORE
Cath Lab Digest
Two new studies examined seasonal variations in cardiac-related hospitalizations specifically for aortic dissection and ST-Elevation Myocardial Infarctions. The results of both studies revealed winter as the most common time for hospital admissions and used the Nationwide Inpatient Sample database for analysis. Results were presented at the Society for Cardiovascular Angiography and Interventions Scientific Sessions in San Diego.
READ MORE
SCAI via EurekAlert
Results of the PERSPECTIVE trial were presented today as late-breaking clinical science at the Society for Cardiovascular Angiography and Interventions 2018 Scientific Sessions. The PERSPECTIVE study is a prospective, single-center rigorously performed clinical trial and reports on one-year outcomes of patients undergoing chronic total occlusion percutaneous coronary intervention treated with Zotarolimus-Eluting Stents. The ZES included in the study were manufactured by Medtronic and represent a modern, newer generation drug-eluting stent.
READ MORE
SCAI via EurekAlert
Revised guidelines incorporating new data on discharge criteria for patients undergoing elective percutaneous coronary intervention will allow for flexibility in length of stay while ensuring patient safety. The guidelines were published in early-view online in SCAI's official journal, Catheterization and Cardiovascular Interventions.
READ MORE
Healio
During the past 40 years, new technologies, treatments and techniques in interventional cardiology have faced intense scrutiny and the community has consistently responded with strong scientific evidence, according to Dr. Roxana Mehran.
"Evidence-based medicine has been the fabric and cloth that we have woven and stands behind everything we do," Mehran, who is associate medical editor of Cardiology Today's Intervention and a cardiologist and professor of medicine at Icahn School of Medicine at Mount Sinai, said during a lecture at the Society for Cardiovascular Angiography and Interventions Scientific Sessions.
READ MORE
SCAI via EurekAlert
A new study looked at the effectiveness of novel risk tool to predict 30-day readmission rates in patients undergoing transcatheter aortic valve replacement. This first ever tool calculates a score to help clinicians and medical professionals predict risk of 30-day readmission for TAVR patients and can be easily incorporated in patient electronic medical records. The study was presented today at the Society for Cardiovascular Angiography and Interventions 2018 Scientific Sessions.
READ MORE
| CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS |
Catheterization and Cardiovascular Interventions via Wiley Online Library
The SKS technique is useful to treat patients with true bifurcation disease of the LMS but remains controversial.
The objective is to perform detailed analysis of stent expansion, vessel wall stress, hemodynamics, reāendothelialization, restenosis, and repeat PCI in the simultaneous kissing stents technique of bifurcation left main stem stenting.
READ MORE
Catheterization and Cardiovascular Interventions via Wiley Online Library
In patients with acute myocardial infarction and cardiogenic shock, percutaneous coronary intervention of the culprit vessel is associated with improved outcomes. A large majority of these patients have multivessel disease. Whether or not PCI of nonāculprit disease in the acute setting improves outcomes continues to be debated. We evaluated the prognostic impact of revascularization strategy for patients presenting with AMI and CS.
READ MORE
HealthDay News via Cardiology Advisor
For patients undergoing surgical aortic valve replacement, previous stroke is a risk factor for recurrent ischemic stroke and major adverse cardiovascular events, according to a study published online April 25 in JAMA Cardiology.
Medscape
The U.S, Food and Drug Administration has approved Medtronic's IN.PACT Admiral drug-coated balloon to treat long superficial femoral artery lesions up to 360 mm in patients with peripheral artery disease, the company announced.
The approval is based on data from the complex lesion imaging cohorts of the IN.PACT Global Study, including long lesion, in-stent restenosis and chronic total occlusion groups with lesion lengths greater than 180 mm.
READ MORE
American Heart Association via HealthDay News
Doctors and African-American communities are obligated to learn more about heart valve disease and the lifesaving procedures available to treat it, according to a report from the Association of Black Cardiologists. "It is incumbent upon us as health care providers [to] do a better job educating our patients about heart valve disease," said Dr. Aaron Horne, Jr., an interventional cardiologist at Methodist Dallas Medical Center.
READ MORE
HealthDay News via WebMD
After a stroke, many patients are given the clot-busting intravenous drug alteplase, but another drug may be more effective, Australian researchers report.
Among more than 200 stroke victims, TNKase was about twice as effective as alteplase in restoring blood flow to the brain, and it also resulted in less disability, the scientists found.
READ MORE
For a complete list of job postings, click here.
To post your resume, click here.
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|